Astrocytes within GBM exhibited a strong immunopositivity for CETN2 (Figures 5A–B”) and appeared tightly clustered in the lesion core compared to the dispersed distribution they present in healthy cerebral parenchyma (Figures 5C–D”). This evidence concerns the gene CETN2 and glioblastoma.